Dr. Amit Sharma, DO

NPI: 1295149102
Total Payments
$7,365
2024 Payments
$2,938
Companies
35
Transactions
171
Medicare Patients
997
Medicare Billing
$60,955

Payment Breakdown by Category

Food & Beverage$7,265 (98.6%)
Education$99.99 (1.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $7,265 170 98.6%
Education $99.99 1 1.4%

Top Paying Companies

Company Total Records Latest Year
Janssen Biotech, Inc. $1,454 16 $0 (2024)
SUN PHARMACEUTICAL INDUSTRIES INC. $558.09 5 $0 (2024)
E.R. Squibb & Sons, L.L.C. $557.30 6 $0 (2024)
ABBVIE INC. $540.15 17 $0 (2024)
PFIZER INC. $424.49 36 $0 (2024)
Galderma Laboratories, L.P. $328.50 2 $0 (2024)
Janssen Scientific Affairs, LLC $326.66 4 $0 (2024)
Amgen Inc. $316.50 3 $0 (2023)
Boehringer Ingelheim Pharmaceuticals, Inc. $297.27 8 $0 (2023)
UCB, Inc. $250.17 3 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,938 42 Janssen Biotech, Inc. ($553.74)
2023 $2,179 34 Janssen Biotech, Inc. ($867.60)
2022 $700.05 13 Janssen Scientific Affairs, LLC ($248.16)
2021 $29.39 2 AbbVie Inc. ($16.46)
2020 $48.33 2 SI-BONE, Inc. ($48.33)
2019 $411.70 12 Boehringer Ingelheim Pharmaceuticals, Inc. ($106.13)
2018 $727.56 51 PFIZER INC. ($221.92)
2017 $331.00 15 Merck Sharp & Dohme Corporation ($118.75)

All Payment Transactions

171 individual payment records from CMS Open Payments — Page 6 of 7

Date Company Product Nature Form Amount Type
07/12/2018 PFIZER INC. LYRICA (Drug), EUCRISA Food and Beverage In-kind items and services $8.06 General
Category: NEUROSCIENCE;PAIN
07/12/2018 PFIZER INC. LYRICA (Drug), EUCRISA Food and Beverage In-kind items and services $0.54 General
Category: NEUROSCIENCE;PAIN
07/10/2018 PFIZER INC. LYRICA (Drug), EUCRISA Food and Beverage In-kind items and services $1.99 General
Category: NEUROSCIENCE;PAIN
07/10/2018 PFIZER INC. LYRICA (Drug), EUCRISA Food and Beverage In-kind items and services $0.29 General
Category: NEUROSCIENCE;PAIN
07/09/2018 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXANIBSD (Drug) Food and Beverage In-kind items and services $13.34 General
Category: GASTROENTEROLOGY
06/26/2018 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $10.89 General
Category: Cardiovascular and Metabolism
06/20/2018 PFIZER INC. PREVNAR - 13 (Biological) Food and Beverage In-kind items and services $12.06 General
Category: VACCINES
06/18/2018 Boehringer Ingelheim Pharmaceuticals, Inc. SPIRIVA RESPIMAT (Drug) Food and Beverage In-kind items and services $17.83 General
Category: RESPIRATORY
06/11/2018 PFIZER INC. CHANTIX (Drug), LYRICA, EUCRISA Food and Beverage In-kind items and services $7.03 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
06/11/2018 PFIZER INC. CHANTIX (Drug), LYRICA, EUCRISA Food and Beverage In-kind items and services $1.20 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
06/05/2018 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $16.37 General
Category: Diabetes
05/18/2018 PFIZER INC. CHANTIX (Drug), LYRICA, FLECTOR PATCH Food and Beverage In-kind items and services $3.82 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
05/16/2018 AbbVie, Inc. Creon (Drug) Food and Beverage In-kind items and services $11.58 General
Category: Endocrinology
05/11/2018 PFIZER INC. CHANTIX (Drug), LYRICA, EUCRISA Food and Beverage In-kind items and services $1.76 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
05/10/2018 PFIZER INC. CHANTIX (Drug), LYRICA, EUCRISA Food and Beverage In-kind items and services $8.00 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
05/10/2018 PFIZER INC. CHANTIX (Drug), LYRICA, EUCRISA Food and Beverage In-kind items and services $0.85 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
05/04/2018 PFIZER INC. CHANTIX (Drug), LYRICA, EUCRISA Food and Beverage In-kind items and services $1.78 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
04/26/2018 Boehringer Ingelheim Pharmaceuticals, Inc. Food and Beverage In-kind items and services $75.59 General
03/28/2018 PFIZER INC. CHANTIX (Drug), LYRICA, EUCRISA Food and Beverage In-kind items and services $7.59 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
03/28/2018 PFIZER INC. CHANTIX (Drug), LYRICA, EUCRISA Food and Beverage In-kind items and services $0.90 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
03/27/2018 Gilead Sciences, Inc. Food and Beverage In-kind items and services $10.76 General
03/27/2018 PFIZER INC. CHANTIX (Drug), LYRICA, EUCRISA Food and Beverage In-kind items and services $9.59 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
03/27/2018 PFIZER INC. CHANTIX (Drug), LYRICA, EUCRISA Food and Beverage In-kind items and services $1.50 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
03/20/2018 Shire North American Group Inc VYVANSE (Drug) Food and Beverage In-kind items and services $20.41 General
Category: NEUROSCIENCE
03/07/2018 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $69.62 General
Category: Cardiovascular and Metabolism

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2022 6 202 371 $21,034 $9,501
2021 7 440 828 $54,325 $32,074
2020 6 355 569 $41,059 $19,380
Total Patients
997
Total Services
1,768
Medicare Billing
$60,955
Procedure Codes
26

All Medicare Procedures & Services

26 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 57 70 $5,527 $2,699 48.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 22 24 $2,841 $1,638 57.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 23 29 $3,567 $1,396 39.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 23 33 $2,616 $1,324 50.6%
17000 Destruction of precancer skin growth, 1 growth Facility 2022 23 34 $2,666 $1,017 38.1%
17110 Destruction of skin growth, 1-14 growths Facility 2022 23 25 $2,212 $897.36 40.6%
99212 Established patient office or other outpatient visit, 10-19 minutes Facility 2022 12 12 $586.82 $343.13 58.5%
17003 Destruction of precancer skin growth, 2-14 growths Facility 2022 19 144 $1,018 $186.39 18.3%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 153 210 $14,109 $10,183 72.2%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 65 91 $10,208 $6,785 66.5%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 47 102 $12,144 $5,903 48.6%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 37 64 $4,521 $2,982 66.0%
17110 Destruction of up to 14 skin growths Facility 2021 44 60 $5,187 $2,623 50.6%
17000 Destruction of skin growth Facility 2021 28 50 $3,463 $1,708 49.3%
17110 Destruction of up to 14 skin growths Office 2021 11 17 $1,997 $737.99 37.0%
99212 Established patient outpatient visit, total time 10-19 minutes Facility 2021 21 21 $742.60 $517.18 69.6%
99441 Physician telephone patient service, 5-10 minutes of medical discussion Facility 2021 11 14 $561.40 $330.72 58.9%
17003 Destruction of 2-14 skin growths Facility 2021 23 199 $1,392 $302.94 21.8%
99213 Established patient office or other outpatient visit, typically 15 minutes Facility 2020 119 166 $10,904 $6,366 58.4%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 35 60 $8,860 $3,614 40.8%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 61 69 $6,729 $3,585 53.3%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 45 61 $7,271 $2,099 28.9%
17110 Destruction of up to 14 skin growths Facility 2020 24 36 $3,060 $1,727 56.4%
17000 Destruction of skin growth Facility 2020 17 28 $1,904 $971.33 51.0%
99212 Established patient office or other outpatient visit, typically 10 minutes Facility 2020 40 46 $1,610 $848.16 52.7%

About Dr. Amit Sharma, DO

Dr. Amit Sharma, DO is a Family Medicine healthcare provider based in Hialeah, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2014. The National Provider Identifier (NPI) number assigned to this provider is 1295149102.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amit Sharma, DO has received a total of $7,365 in payments from pharmaceutical and medical device companies, with $2,938 received in 2024. These payments were reported across 171 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($7,265).

As a Medicare-enrolled provider, Sharma has provided services to 997 Medicare beneficiaries, totaling 1,768 services with total Medicare billing of $60,955. Data is available for 3 years (2020–2022), covering 26 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Other Specialties General Acute Care Hospital, General Acute Care Hospital
  • Location Hialeah, FL
  • Active Since 06/18/2014
  • Last Updated 10/11/2022
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1295149102

Products in Payments

  • TREMFYA (Drug) $1,781
  • Sotyktu (Drug) $546.49
  • DUPIXENT (Biological) $324.69
  • ILUMYA (Biological) $278.38
  • Bimzelx (Biological) $218.98
  • OPZELURA (Drug) $185.76
  • RINVOQ (Biological) $172.50
  • NATRELLE SALINE-FILLED BREAST IMPLANTS (Device) $165.15
  • SKYRIZI (Biological) $162.04
  • VRAYLAR (Drug) $151.14
  • TWYNEO (Drug) $146.54
  • CIBINQO (Drug) $146.41
  • Winlevi (Drug) $136.82
  • FARXIGA (Drug) $122.61
  • VTAMA (Drug) $118.18
  • Otezla (Drug) $116.84
  • COSENTYX (Biological) $116.08
  • JUBLIA (Drug) $111.74
  • VYJUVEK (Drug) $100.69
  • NEXPLANON (Drug) $89.73

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Hialeah